Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters










Publication year range
1.
Biometals ; 36(3): 437-462, 2023 06.
Article in English | MEDLINE | ID: mdl-36334191

ABSTRACT

The pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection involves dysregulations of iron metabolism, and although the mechanism of this pathology is not yet fully understood, correction of iron metabolism pathways seems a promising pharmacological target. The previously observed effect of inhibiting SARS-CoV-2 infection by ferristatin II, an inducer of transferrin receptor 1 (TfR1) degradation, prompted the study of competition between Spike protein and TfR1 ligands, especially lactoferrin (Lf) and transferrin (Tf). We hypothesized molecular mimicry of Spike protein as cross-reactivity of Spike-specific antibodies with Tf and Lf. Thus, strong positive correlations (R2 > 0.95) were found between the level of Spike-specific IgG antibodies present in serum samples of COVID-19-recovered and Sputnik V-vaccinated individuals and their Tf-binding activity assayed with peroxidase-labeled anti-Tf. In addition, we observed cross-reactivity of Lf-specific murine monoclonal antibody (mAb) towards the SARS-CoV-2 Spike protein. On the other hand, the interaction of mAbs produced to the receptor-binding domain (RBD) of the Spike protein with recombinant RBD protein was disrupted by Tf, Lf, soluble TfR1, anti-TfR1 aptamer, as well as by peptides RGD and GHAIYPRH. Furthermore, direct interaction of RBD protein with Lf, but not Tf, was observed, with affinity of binding estimated by KD to be 23 nM and 16 nM for apo-Lf and holo-Lf, respectively. Treatment of Vero E6 cells with apo-Lf and holo-Lf (1-4 mg/mL) significantly inhibited SARS-CoV-2 replication of both Wuhan and Delta lineages. Protective effects of Lf on different arms of SARS-CoV-2-induced pathogenesis and possible consequences of cross-reactivity of Spike-specific antibodies are discussed.


Subject(s)
COVID-19 , Lactoferrin , Molecular Mimicry , Spike Glycoprotein, Coronavirus , Transferrin , Animals , Humans , Mice , Iron/metabolism , Lactoferrin/chemistry , SARS-CoV-2 , Spike Glycoprotein, Coronavirus/chemistry , Spike Glycoprotein, Coronavirus/metabolism , Transferrin/chemistry
2.
Arch Biochem Biophys ; 728: 109353, 2022 10 15.
Article in English | MEDLINE | ID: mdl-35853481

ABSTRACT

Myeloperoxidase (MPO), an oxidant-producing enzyme of neutrophils, has been shown to prime platelet activity promoting immunothrombosis. Native MPO is a homodimer, consisting of two identical protomers (monomer) connected by a single disulfide bond. But in inflammatory foci, MPO can be found both in the form of a monomer and in the form of a dimer. Beside MPO can also be in complexes with other molecules and be modified by oxidants, which ultimately affect its physicochemical properties and functions. Here we compared the effects of various forms of MPO as well as MPO in complex with ceruloplasmin (CP), a physiological inhibitor of MPO, on the platelet activity. Monomeric MPO (hemi-MPO) was obtained by treating the dimeric MPO by reductive alkylation. MPO was modified with HOCl in a molar ratio of 1:100 (MPO-HOCl). Using surface-enhanced Raman scattering (SERS) spectroscopy we showed that peaks at about 510 and 526 cm-1 corresponded to disulfide bond was recognizable in the SERS-spectra of dimeric MPO, absent in the spectrum of hemi-MPO and less intense in the spectra of MPO-HOCl, which indicates the partial decomposition of dimeric MPO with a disulfide bond cleavage under the HOCl modification. It was shown hemi-MPO to a lesser extent than dimeric MPO bound to platelets and enhanced their agonist-induced aggregation and platelet-neutrophil aggregate formation. MPO modified by HOCl and MPO in complex with CP did not bind to platelets and have no effect on platelet activity. Thus, the modification of MPO by HOCl, its presence in monomeric form as well as in complex with CP reduces MPO effect on platelet function and consequently decreases the risk of thrombosis in inflammatory foci.


Subject(s)
Neutrophils , Peroxidase , Coloring Agents , Disulfides , Hypochlorous Acid , Oxidants , Platelet Activation
3.
Biochem Cell Biol ; 99(1): 109-116, 2021 02.
Article in English | MEDLINE | ID: mdl-32544357

ABSTRACT

Myeloperoxidase (MPO) is a unique heme-containing peroxidase that can catalyze the formation of hypochlorous acid (HOCl). The strong interaction of MPO with low-density lipoproteins (LDL) promotes proatherogenic modification of LDL by HOCl. The MPO-modified LDL (Mox-LDL) accumulate in macrophages, resulting in the formation of foam cells, which is the pathognomonic symptom of atherosclerosis. A promising approach to prophylaxis and atherosclerosis therapy is searching for remedies that prevent the modification or accumulation of LDL in macrophages. Lactoferrin (LF) has several application points in obesity pathogenesis. We aimed to study LF binding to Mox-LDL and their accumulation in monocytes transformed into macrophages. Using surface plasmon resonance and ELISA techniques, we observed no LF interaction with intact LDL, whereas Mox-LDL strongly interacted with LF. The affinity of Mox-LDL to LF increased with the degree of oxidative modification of LDL. Moreover, an excess of MPO did not prevent interaction of Mox-LDL with LF. LF inhibits accumulation of cholesterol in macrophages exposed to Mox-LDL. The results obtained reinforce the notion of LF potency as a remedy against atherosclerosis.


Subject(s)
Cholesterol/metabolism , Lactoferrin/metabolism , Lipoproteins, LDL/metabolism , Monocytes/metabolism , Peroxidase/metabolism , Cells, Cultured , Cholesterol/blood , Cholesterol/chemistry , Healthy Volunteers , Humans , Lactoferrin/blood , Lactoferrin/chemistry , Lipoproteins, LDL/blood , Lipoproteins, LDL/chemistry , Milk, Human/chemistry , Milk, Human/metabolism , Monocytes/chemistry , Peroxidase/blood , Peroxidase/chemistry , Protein Binding , Surface Properties
4.
Biochemistry (Mosc) ; 84(6): 652-662, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31238865

ABSTRACT

Neutrophil myeloperoxidase (MPO) plays an important role in protecting the body against infections. MPO products - hypohalous acids and phenoxyl radicals - are strong oxidants that can damage not only foreign intruders but also host tissues, including blood plasma proteins. Here, we compared the MPO-induced oxidation of two plasma proteins with antioxidant properties - human serum albumin (HSA) and ceruloplasmin (CP). Incubation of both proteins with hypochlorite (NaOCl) or catalytically active MPO (MPO + H2O2), which synthesizes hypochlorous acid (HOCl) in the presence of chloride ions, resulted in the quenching of protein tryptophan fluorescence. Oxidation-induced changes in the structures of HSA and CP were different. HSA efficiently neutralized MPO-generated oxidants without protein aggregation, while CP oxidation resulted in the formation of large aggregates stabilized by strong covalent bonds between the aromatic amino acid residues. Tyrosine is present in the plasma as free amino acid and also as a component of the polypeptide chains of the proteins. The number of tyrosine residues in a protein does not determine its propensity for aggregate formation. In the case of CP, protein aggregation was primarily due to the high content of tryptophan residues in its polypeptide chain. MPO-dependent oxidation of free tyrosine results in the formation of tyrosyl radicals, that do not oxidize aromatic amino acid residues in proteins because of the high rate of recombination with dityrosine formation. At the same time, free tyrosine can influence MPO-induced protein oxidation due to its ability to modulate HOCl synthesis in the MPO active site.


Subject(s)
Albumins/metabolism , Ceruloplasmin/metabolism , Peroxidase/metabolism , Tyrosine/metabolism , Antioxidants/metabolism , Humans , Oxidation-Reduction
5.
Biomed Khim ; 64(5): 433-438, 2018 Sep.
Article in Russian | MEDLINE | ID: mdl-30378560

ABSTRACT

Oxidative stress and neutrophil activation leading to an increase in myeloperoxidase (MPO), elastase and neutrophil extracellular trap (NET) levels in blood are considered as pathogenic mechanisms responsible for the development of extremity damage in people with type 2 diabetes mellitus (T2DM). The aim of this study was to analyze the relationship between factors, associated with neutrophil activation, and the length of the initial phase of wound healing (the inflammatory phase) in T2DM patients. Patients were divided retrospectively into three groups depending on the damage extent: group 1 (wound on toe) < group 2 (wound on foot) < group 3 (wound on lower leg). Compared to the control group (healthy volunteers), T2DM patients at admission to hospital had significantly (p<0.05) increased levels of blood glucose and glycated hemoglobin (groups 1-3), ESR (groups 1 and 3), blood neutrophil count (groups 2 and 3), plasma MPO concentration (groups 1-3) and blood NET concentration (group 3) and decreased levels of plasma thiols (groups 1-3) and erythrocyte glutathione peroxidase activity (groups 2 and 3). The length of hospital stay after surgical procedures corresponded to the length of the inflammatory phase of the wound healing process and correlated with the number of blood neutrophils in patients before surgery (r=0.72, p<0.05). Leukocytic intoxication index depended on wound area (r=0.59, p<0.05), and it was significantly higher for groups 2 and 3 compared to the control group and group 1. The neutrophil count before surgery in T2DM patients with damage in the lower extremities correlated with the length of the inflammatory phase of wound healing. The correlation found can be attributed to an increase in extracellular MPO and NETs, which, in its turn, results from the activation and degranulation of neutrophils and netosis. Thus, the duration of the inflammatory phase of wound healing depends on specific aspects of systemic inflammation increasing oxidative/halogenative stress and intoxication.


Subject(s)
Diabetes Mellitus, Type 2 , Neutrophils , Extracellular Traps , Humans , Peroxidase , Retrospective Studies , Wound Healing
6.
Biochemistry (Mosc) ; 83(6): 701-707, 2018 Jun.
Article in English | MEDLINE | ID: mdl-30195326

ABSTRACT

Macrophage migration inhibitory factor (MIF) is a key proinflammatory cytokine. Inhibitors of tautomerase activity of MIF are perspective antiinflammatory compounds. Ceruloplasmin, the copper-containing ferroxidase of blood plasma, is a noncompetitive inhibitor of tautomerase activity of MIF in the reaction with p-hydroxyphenylpyruvate. Small-angle X-ray scattering established a model of the complex formed by MIF and ceruloplasmin. Crystallographic analysis of MIF with a modified active site supports the model. The stoichiometry of 3 CP/MIF trimer complex was established using gel filtration. Conformity of novel data concerning the interaction regions in the studied proteins with previous biochemical data is discussed.


Subject(s)
Ceruloplasmin/metabolism , Macrophage Migration-Inhibitory Factors/metabolism , Ceruloplasmin/chemistry , Chromatography, Gel , Copper/chemistry , Copper/metabolism , Crystallography, X-Ray , Fluorescein-5-isothiocyanate/chemistry , Humans , Isothiocyanates/chemistry , Macrophage Migration-Inhibitory Factors/chemistry , Macrophage Migration-Inhibitory Factors/genetics , Protein Binding , Protein Structure, Quaternary , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , Scattering, Small Angle , X-Ray Diffraction
7.
Biomed Khim ; 64(2): 175-182, 2018 Mar.
Article in Russian | MEDLINE | ID: mdl-29723147

ABSTRACT

This study was carried out to compare the enzymatic and bactericidal activity of mature, dimeric myeloperoxidase (MPO) and its monomeric form. Dimeric MPO was isolated from HL-60 cells. Hemi-MPO obtained from dimeric MPO by reductive cleavage of a disulfide bond between protomeric subunits was used as the monomeric form. Both peroxidase and halogenating (chlorinating) activities of MPO were assayed, each of them by two methods. Bactericidal activity of the MPO/Н2О2/Cl- system was tested using the Escherichia coli laboratory strain DH5a. No difference in the enzymatic and bactericidal activity between dimeric MPO and hemi-MPO was found. Both forms of the enzyme also did not differ in the resistance to HOCl, the main product of MPO. HOCl caused a dose-dependent decrease in peroxidase and chlorinating activity, and the pattern of this decrease was identical for dimeric MPO and hemi-MPO. At equal heme concentration, a somewhat higher bactericidal effect was observed for the hemi-MPO/Н2О2/Cl- system compared with the dimeric MPO/Н2О2/Cl- system. However, this is most likely not related to some specific property of hemi-MPO and can be accounted for by the higher probability of contacting between bacterial surface and hemi-MPO molecules due to their two-fold greater number relative to that of dimeric MPO molecules at the same heme concentration. By using Western-blotting with antibodies to MPO, we showed, for the first time, that the dimeric molecule of MPO could be cleaved into two monomeric subunits by HOCl, most probably due to oxidation of the disulfide bond between these subunits. This finding suggests that appearance in blood of MPO corresponding in mass to its monomer may result from the damage of dimeric MPO by reactive halogen species, especially upon their overproduction underlying oxidative/halogenative stress in inflammatory diseases.


Subject(s)
Escherichia coli/growth & development , Peroxidase/metabolism , Humans , Hypochlorous Acid , Molecular Weight , Oxidation-Reduction
8.
Biometals ; 31(3): 425-443, 2018 06.
Article in English | MEDLINE | ID: mdl-29748743

ABSTRACT

Among the properties of lactoferrin (LF) are bactericidal, antianemic, immunomodulatory, antitumour, antiphlogistic effects. Previously we demonstrated its capacity to stabilize in vivo HIF-1-alpha and HIF-2-alpha, which are redox-sensitive multiaimed transcription factors. Various tissues of animals receiving recombinant human LF (rhLF) responded by expressing the HIF-1-alpha target genes, hence such proteins as erythropoietin (EPO), ceruloplasmin, etc. were synthesized in noticeable amounts. Among organs in which EPO synthesis occurred were brain, heart, spleen, liver, kidneys and lungs. Other researchers showed that EPO can act as a protectant against severe brain injury and status epilepticus in rats. Therefore, we tried rhLF as a protector against the severe neurologic disorders developed in rats, such as the rotenone-induced model of Parkinson's disease and experimental autoimmune encephalomyelitis as a model of multiple sclerosis, and observed its capacity to mitigate the grave symptoms. Moreover, an intraperitoneal injection of rhLF into mice 1 h after occlusion of the medial cerebral artery significantly diminished the necrosis area measured on the third day in the ischaemic brain. During this period EPO was synthesized in various murine tissues. It was known that EPO induces nuclear translocation of Nrf2, which, like HIF-1-alpha, is a transcription factor. In view that under conditions of hypoxia both factors demonstrate a synergistic protective effect, we suggested that LF activates the Keap1/Nrf2 signaling pathway, an important link in proliferation and differentiation of normal and malignant cells. J774 macrophages were cultured for 3 days without or in the presence of ferric and ferrous ions (RPMI-1640 and DMEM/F12, respectively). Then cells were incubated with rhLF or Deferiprone. Confocal microscopy revealed nuclear translocation of Nrf2 (the key event in Keap1/Nrf2 signaling) induced by apo-rhLF (iron-free, RPMI-1640). The reference compound Deferiprone (iron chelator) had the similar effect. Upon iron binding (in DMEM/F12) rhLF did not activate the Keap1/Nrf2 pathway. Added to J774, apo-rhLF enhanced transcription of Nrf2-dependent genes coding for glutathione S-transferase P and heme oxygenase-1. Western blotting revealed presence of Nrf2 in mice brain after 6 days of oral administration of apo-rhLF, but not Fe-rhLF or equivalent amount of PBS. Hence, apo-LF, but not holo-LF, induces the translocation of Nrf2 from cytoplasm to the nucleus, probably due to its capacity to induce EPO synthesis.


Subject(s)
Erythropoietin/metabolism , Lactoferrin/metabolism , NF-E2-Related Factor 2/metabolism , Neuroprotection , Neuroprotective Agents/therapeutic use , Animals , Brain Ischemia/drug therapy , Encephalomyelitis, Autoimmune, Experimental/chemically induced , Encephalomyelitis, Autoimmune, Experimental/drug therapy , Erythropoietin/administration & dosage , Female , Humans , Lactoferrin/administration & dosage , Male , Mice , Mice, Inbred BALB C , Multiple Sclerosis/drug therapy , NF-E2-Related Factor 2/administration & dosage , Neuroprotective Agents/administration & dosage , Neuroprotective Agents/metabolism , Parkinson Disease/drug therapy , Rats , Rats, Wistar , Recombinant Proteins/administration & dosage , Recombinant Proteins/metabolism
9.
Biomed Khim ; 64(1): 16-22, 2018 Jan.
Article in Russian | MEDLINE | ID: mdl-29460830

ABSTRACT

Exocytosis of myeloperoxidase (MPO) from activated neutrophils in the presence of the anionic polysaccharide heparin was studied. It was determined that the optimal concentration of heparin (0.1 u/ml), at which there is no additional activation of cells (absence of amplification of exocytosis of lysozyme contained in specific and azurophilic granules). It was found that after preincubation of cells with heparin (0.1 u/ml) the exocytosis of MPO from neutrophils activated by various stimulants (fMLP, PMA, plant lectins CABA and PHA-L) increased compared to that under the action of activators alone. In addition, it was shown that heparin in the range of concentrations 0.1-50 u/ml did not affect on the peroxidase activity of the MPO isolated from leukocytes. Thus, the use of heparin at a concentration of 0.1 u/ml avoids the artifact caused by the "loss" of MPO in a result of its binding to neutrophils, and increases the accuracy of the method of registration the degranulation of azurophilic granules of neutrophils based on determination of the concentration or peroxidase activity of MPO in cell supernatants.


Subject(s)
Exocytosis , Neutrophils , Cytoplasmic Granules , Heparin , Peroxidase
10.
Biochem Cell Biol ; 96(4): 457-467, 2018 08.
Article in English | MEDLINE | ID: mdl-29370542

ABSTRACT

CP is a copper-containing ferroxidase of blood plasma, which acts as an acute phase reactant during inflammation. The effect of oxidative modification of CP induced by oxidants produced by MPO, such as HOCl, HOBr, and HOSCN, on its spectral, enzymatic, and anti-inflammatory properties was studied. We monitored the chemiluminescence of lucigenin and luminol along with fluorescence of hydroethidine and scopoletin to assay the inhibition by CP of the neutrophilic respiratory burst induced by PMA or fMLP. Superoxide dismutase activity of CP and its capacity to reduce the production of oxidants in respiratory burst of neutrophils remained virtually unchanged upon modifications caused by HOCl, HOBr, and HOSCN. Meanwhile, the absorption of type I copper ions at 610 nm became reduced, along with a drop in the ferroxidase and amino oxidase activities of CP. Likewise, its inhibitory effect on the halogenating activity of MPO was diminished. Sera of either healthy donors or patients with Wilson disease were co-incubated with neutrophils from healthy volunteers. In these experiments, we observed an inverse relationship between the content of CP in sera and the rate of H2O2 production by activated neutrophils. In conclusion, CP is likely to play a role of an anti-inflammatory factor tempering the neutrophil respiratory burst in the bloodstream despite the MPO-mediated oxidative modifications.


Subject(s)
Ceruloplasmin/pharmacology , Neutrophils/drug effects , Peroxidase/drug effects , Respiratory Burst/drug effects , Ceruloplasmin/metabolism , Humans , Hydrogen Peroxide/metabolism , Neutrophils/metabolism , Oxidation-Reduction/drug effects , Peroxidase/metabolism
11.
Biochemistry (Mosc) ; 82(9): 1073-1078, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28988537

ABSTRACT

The year 2016 marked the 50th anniversary of the discovery by S. Osaki who first showed that ceruloplasmin (CP, ferro:O2-oxidoreductase or ferroxidase) is capable of oxidizing Fe(II) to Fe(III) and favors the incorporation of the latter into transferrin (TF). However, much debate remains in the literature concerning the existence of a complex between the enzyme oxidizing iron and the protein facilitating its transport in plasma. We studied CP in exocrine fluids and demonstrated its high-affinity interaction with transferrin found in breast milk and in lacrimal fluid, i.e. with lactoferrin (LF). Here we present data obtained by comparing the interaction of CP with LF and TF using surface plasmon resonance and Hummel-Dreyer chromatography. Binding of apo-LF within the range of concentrations 1.6-51.3 µM with CP immobilized on a CM5-chip is characterized by KD = 1.07 µM. Under similar conditions, the KD for apo-TF was measured and appeared to be higher than 51.3 µM. Hummel-Dreyer chromatography of CP with 51 µM apo-LF/apo-TF in the effluent demonstrated the absence of interaction between apo-TF and CP in solution, contrary to efficient interaction between apo-LF and CP. In contrast to LF, the interaction of apo-TF with CP is probably not stable within the physiological range of concentrations of TF.


Subject(s)
Ceruloplasmin/metabolism , Lactoferrin/metabolism , Milk, Human/chemistry , Tears/chemistry , Transferrin/metabolism , Female , Humans , Milk, Human/metabolism , Protein Binding , Tears/metabolism
12.
Bull Exp Biol Med ; 161(4): 495-500, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27597056

ABSTRACT

Myeloperoxidase, heme enzyme of azurophilic granules in neutrophils, is released into the extracellular space in the inflammation foci. In neutrophils, it stimulates a dose-dependent release of lactoferrin (a protein of specific granules), lysozyme (a protein of specific and azurophilic granules), and elastase (a protein of azurophilic granules). 4-Aminobenzoic acid hydrazide, a potent inhibitor of peroxidase activity of myeloperoxidase, produced no effect on neutrophil degranulation. Using signal transduction inhibitors (genistein, methoxyverapamil, wortmannin, and NiCl2), we demonstrated that myeloperoxidase-induced degranulation of neutrophils resulted from enzyme interaction with the plasma membrane and depends on activation of tyrosine kinases, phosphatidylinositol 3-kinases (PI3K), and calcium signaling. Myeloperoxidase modified by oxidative/halogenation stress (chlorinated and monomeric forms of the enzyme) lost the potency to activate neutrophil degranulation.


Subject(s)
Neutrophils/metabolism , Peroxidase/metabolism , 4-Aminobenzoic Acid/pharmacology , Androstadienes/pharmacology , Calcium Signaling/drug effects , Cell Degranulation/drug effects , Cells, Cultured , Gallopamil/pharmacology , Genistein/pharmacology , HL-60 Cells , Humans , Neutrophils/drug effects , Nickel/pharmacology , Oxidative Stress/drug effects , Peroxidase/antagonists & inhibitors , Phosphatidylinositol 3-Kinases/metabolism , Signal Transduction/drug effects , Wortmannin
13.
Biomed Khim ; 62(3): 318-24, 2016 Mar.
Article in Russian | MEDLINE | ID: mdl-27420626

ABSTRACT

A significant increase in the myeloperoxidase (MPO) activity has been found in plasma of patients with stable angina and with acute coronary syndrome (ACS) in comparison with the control group. MPO concentration was significantly increased in plasma of ACS patients. Reduced MPO activity in the treated ACS patients correlated with a favorable outcome of the disease. Generally, changes in plasma MPO concentration coincided with changes in lactoferrin concentration thus confirming the role of neutrophil degranulation in the increase of plasma concentrations of these proteins. The increase in MPO activity was obviously determined by modification of the MPO protein caused by reactive oxygen species and halogen in the molar ratio of 1 : 25 and 1 : 50. The decrease in plasma MPO activity may be associated with increased plasma concentrations of the physiological inhibitor of its activity, ceruloplasmin, and also with modification of the MPO protein with reactive oxygen species and halogen at their molar ratio of 1 : 100 and higher. Thus, MPO activity may be used for evaluation of effectiveness of the treatment of cardiovascular diseases.


Subject(s)
Acute Coronary Syndrome/blood , Angina, Stable/blood , Peroxidase/blood , Acute Coronary Syndrome/pathology , Angina, Stable/pathology , Biomarkers/blood , Case-Control Studies , Ceruloplasmin/metabolism , Female , Humans , Lactoferrin/blood , Male , Middle Aged
14.
Free Radic Res ; 49(6): 777-89, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25790937

ABSTRACT

Myeloperoxidase (MPO) is a challenging molecular target which, if put under control, may allow regulating the development of inflammatory reactions associated with oxidative/halogenative stress. In this paper, a new kinetic method for assaying the halogenating activity of MPO is described. The method is based on measuring the rate of iodide-catalyzed oxidation of celestine blue B (CB) by oxygen and taurine N-chloramine (bromamine). The latter is produced in a reaction of taurine with HOCl (HOBr). CB is not a substrate for the peroxidase activity of MPO and does not react with hydrogen peroxide and superoxide anion radical. Taurine N-chloramine (bromamine) reacts with CB in molar ratio of 1:2. Using the new method, we studied the dependence of MPO activity on concentration of substrates and inhibitors. The specificity of MPO inhibition by non-proteolyzed ceruloplasmin is characterized. The inhibition of taurine N-chloramine production by neutrophils and HL-60 cells in the presence of MPO-affecting substances is demonstrated. The new method allows determining the kinetic parameters of MPO halogenating activity and studying its inhibition by various substances, as well as screening for potential inhibitors of the enzyme.


Subject(s)
Coloring Agents/chemistry , Enzyme Assays/methods , Halogenation , Oxazines/chemistry , Peroxidase/metabolism , Taurine/analogs & derivatives , Bromides/chemistry , Ceruloplasmin/metabolism , Enzyme Inhibitors/metabolism , HL-60 Cells , Humans , Kinetics , Neutrophils/enzymology , Peroxidase/analysis , Peroxidase/antagonists & inhibitors , Taurine/chemistry
15.
Free Radic Res ; 49(6): 800-11, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25762223

ABSTRACT

Myeloperoxidase (MPO) and eosinophil peroxidase (EPO) are involved in the development of halogenative stress during inflammation. We previously described a complex between MPO and ceruloplasmin (CP). Considering the high structural homology between MPO and EPO, we studied the latter's interaction with CP and checked whether EPO becomes inhibited in a complex with CP. Disc-electrophoresis and gel filtration showed that CP and EPO form a complex with the stoichiometry 1:1. Affinity chromatography of EPO on CP-agarose (150 mM NaCl, 10 mM Na-phosphate buffer, of pH 7.4) resulted in retention of EPO. EPO protects ceruloplasmin from limited proteolysis by plasmin. Only intact CP shifted the Soret band typical of EPO from 413 to 408 nm. The contact with CP likely causes changes in the heme pocket of EPO. Peroxidase activity of EPO with substrates such as guaiacol, orcinol, o-dianisidine, 4-chloro-1-naphtol, 3,3',5,5'-tetramethylbenzidine, and 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonate) is inhibited by CP in a dose-dependent manner. Similar to the interaction with MPO, the larger a substrate molecule, the stronger the inhibitory effect of CP upon EPO. The limited proteolysis of CP abrogates its capacity to inhibit the peroxidase activity of EPO. The peptide RPYLKVFNPR (corresponding to amino acids 883-892 in CP) inhibits the peroxidase and chlorinating activity of EPO. Only the chlorinating activity of EPO is efficiently inhibited by CP, while the capacity of EPO to oxidize bromide and thiocyanate practically does not depend on the presence of CP. EPO enhances the p-phenylenediamine-oxidase activity of CP. The structural homology between the sites in the MPO and EPO molecules enabling them to contact CP is discussed.


Subject(s)
Ceruloplasmin/metabolism , Eosinophil Peroxidase/metabolism , Peroxidase/metabolism , Animals , Enzyme Inhibitors/metabolism , Eosinophil Peroxidase/antagonists & inhibitors , Halogenation , Humans , Kinetics , Peroxidase/antagonists & inhibitors , Peroxidase/blood , Peroxidase/immunology , Protein Binding , Protein Structure, Tertiary
16.
Biofizika ; 58(4): 681-9, 2013.
Article in Russian | MEDLINE | ID: mdl-24455888

ABSTRACT

It is shown that human serum albumin, previously treated with HOCl (HSA-Cl), enhances luminol-dependent chemiluminescence of neutrophils activated by phorbol-12-myristate-13-acetate (PMA). The enzyme-linked immunosorbent assay revealed that addition of HSA-Cl to neutrophils promotes exocytosis of myeloperoxidase. Inhibitor of myeloperoxidase--4-aminobenzoic acid hydrazide, without any effect on lucigenin-dependent chemiluminescence of neutrophils stimulated with PMA, effectively suppressed luminol-dependent chemiluminescence (IC50 = 20 microM) under the same conditions. The transfer of the cells from medium with HSA-Cl and myeloperoxidase to fresh medium abolished an increase in PMA-induced luminol-dependent chemiluminescence, but not the ability of neutrophils to respond to re-addition of HSA-Cl. A direct and significant (r = 0.75, p) correlation was observed between the intensity of PMA stimulated neutrophil chemiluminescence response and myeloperoxidase activity in the cell-free media after chemiluminescence measurements. These results suggest the involvement of myeloperoxidase in the increase of neutrophil PMA-stimulated chemiluminescence response in the presence of HSA-Cl. A significant positive correlation was found between myeloperoxidase activity in blood plasma of children with severe burns and the enhancing effects of albumin fraction of the same plasma on luminol-dependent chemiluminescence of PMA-stimulated donor neutrophils. These results support a hypothesis that proteins modified in reactions involving myeloperoxidase under oxidative/halogenative stress, stimulate neutrophils, leading to exocytosis of myeloperoxidase, a key element of halogenative stress, and to closing a "vicious circle" of neutrophil activation at the inflammatory site.


Subject(s)
Burns/enzymology , Luminol/chemistry , Neutrophils/drug effects , Peroxidase/metabolism , Serum Albumin/pharmacology , Aniline Compounds/pharmacology , Burns/pathology , Child , Enzyme Inhibitors/pharmacology , Enzyme-Linked Immunosorbent Assay , Humans , Hypochlorous Acid/chemistry , Luminescence , Luminescent Measurements , Neutrophil Activation/drug effects , Neutrophils/enzymology , Neutrophils/metabolism , Neutrophils/pathology , Oxidative Stress , Peroxidase/antagonists & inhibitors , Phorbol Esters/pharmacology , Serum Albumin/chemistry
17.
Biochemistry (Mosc) ; 77(6): 631-8, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22817463

ABSTRACT

A two-stage chromatography that yields highly purified ceruloplasmin (CP) from human plasma and from rat and rabbit serum is described. The isolation procedure is based on the interaction of CP with neomycin, and it provides a high yield of CP. Constants of inhibition by gentamycin, kanamycin, and neomycin of oxidase activity of CP in its reaction with p-phenylenediamine were assayed. The lowest K(i) for neomycin (11 µM) corresponded to the highest specific adsorption of CP on neomycin-agarose (10 mg CP/ml of resin). Isolation of CP from 1.4 liters of human plasma using ion-exchange chromatography on UNO-Sphere Q and affinity chromatography on neomycin-agarose yields 348 mg of CP with 412-fold purification degree. Human CP preparation obtained with A(610)/A(280) ~ 0.052 contained neither immunoreactive prothrombin nor active thrombin. Upon storage at 37°C under sterile conditions, the preparation remained stable for two months. Efficient preparation of highly purified CP from rat and rabbit sera treated according to a similar protocol suggests the suitability of our method for isolation of CP from plasma and serum of other animals. The yield of CP in three separate purifications was no less than 78%.


Subject(s)
Ceruloplasmin/isolation & purification , Chromatography, Affinity/methods , Neomycin/chemistry , Animals , Ceruloplasmin/antagonists & inhibitors , Chromatography, Ion Exchange , Gentamicins/chemistry , Gentamicins/metabolism , Humans , Kanamycin/chemistry , Kanamycin/metabolism , Neomycin/metabolism , Phenylenediamines/chemistry , Protein Binding , Rabbits , Rats , Sepharose/chemistry , Serum/chemistry
18.
Bull Exp Biol Med ; 154(1): 23-6, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23330081

ABSTRACT

We performed a comparative analysis of functional activity of neutrophils in patients with type 2 diabetes mellitus with and without symptoms of CHD. Enhanced H2O2 production by neutrophils in response to N-formyl-Met-Leu-Phe (fMLP) was found in patients with type 2 diabetes mellitus. In patients with type 2 diabetes mellitus associated with CHD, fMLP-induced release of myeloperoxidase from azurophilic granules of neutrophils was reduced and plasma myeloperoxidase level was elevated. Increased peroxidase activity of myeloperoxidase, reduced plasma catalase activity, and increased levels of TBA-reactive lipid peroxidation products and oxidized glutathione were detected in patients of both groups. Since myeloperoxidase is an important neutrophilic mediator of oxidative stress, its increased activity in the blood can be an additional marker of oxidative stress and cardiovascular risk in patients with diabetes mellitus.


Subject(s)
Coronary Disease/metabolism , Diabetes Mellitus, Type 2/metabolism , N-Formylmethionine Leucyl-Phenylalanine/analogs & derivatives , Neutrophils/metabolism , Peroxidase/metabolism , Catalase/metabolism , Enzyme Activation , Glutathione/metabolism , Humans , Hydrogen Peroxide/metabolism , Middle Aged , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Oxidative Stress , Reactive Oxygen Species/metabolism
19.
Bioorg Khim ; 37(4): 510-21, 2011.
Article in Russian | MEDLINE | ID: mdl-22096994

ABSTRACT

Broad prospects for the use of single-walled carbon nanotubes (SWNTs) in medicine and biotechnology raise the concerns about both their toxicity, and the mechanisms of biodegradation and excretion from the body. SWNTs biodegradation as a result of catalytic activity of myeloperoxidase (MPO) was shown in the isolated MPO system as well as in the suspension of neutrophils [Kagan V.E., et al., 2010]. In the present study we analyzed the ability of different MPO-produced oxidants to participate in the modification and degradation of SWNTs. The comparison of the ability of various peroxidases to degrade SWNTs in vitro revealed that myeloperoxidase, due to its ability to produce hypochlorite, and lactoperoxidase, due to its ability to produce hypobromite, are extremely efficient in the degradation of carbon nanotubes. The biodegradation of SWNTs in the model system can also be caused by free radicals generated as a result of heme degradation and, to a lesser extent, by active oxoferryl intermediates of peroxidases. Our experiments showed that in the presence of blood plasma, peroxidase intermediates or free radical products of heme degradation were unable to initiate biodegradation of carbon nanotubes, only the generation of hypochlorite by MPO can cause the biodegradation of carbon nanotubes in vivo. Titration of SWNTs suspension containing plasma with hypochlorite at high concentrations resulted in the decrease in the optical absorbance of the suspension indicating the degradation of nanotubes. Our results clearly indicate that hypochlorite can serve as a main oxidizing agent which is able to modify and degrade nanotubes in the sites of inflammation and in the phagosomes.


Subject(s)
Hypochlorous Acid/chemical synthesis , Nanotubes, Carbon/chemistry , Peroxidase/chemistry , Biodegradation, Environmental , Humans , Lactoperoxidase/chemistry , Oxidation-Reduction , Plasma/chemistry
20.
Bull Exp Biol Med ; 149(2): 219-22, 2010 Aug.
Article in English, Russian | MEDLINE | ID: mdl-21113495

ABSTRACT

The effect of human lactoferrin on the arrest of experimental hemorrhagic anemia consequences was studied in rats. After six blood losses (days 1-4 and 7-8 of the experiment), the rats developed acute anemia: hemoglobin concentration decreased to 59% of the initial level, serum iron level decreased 3-fold. Intraperitoneal injections of lactoferrin (10 mg/day) for 4 days starting from day 7 led to an increase in hemoglobin level to 109% and of serum iron to 125% on day 14. In controls, hemoglobin level on day 14 was 70% and iron content 49% of the initial level. Ferroxidase activity of ceruloplasmin in blood serum decreased after 5 blood losses returned to normal only in rats receiving lactoferrin. The results indicate that lactoferrin modified ceruloplasmin activity in vivo, promoting normalization of iron metabolism.


Subject(s)
Anemia/drug therapy , Iron/metabolism , Lactoferrin/pharmacology , Lactoferrin/therapeutic use , Animals , Ceruloplasmin/metabolism , Chromatography, Ion Exchange , Erythrocyte Indices/drug effects , Humans , Injections, Intraperitoneal , Iron/blood , Lactoferrin/administration & dosage , Male , Milk, Human/chemistry , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...